Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  AUSTRALIAN SECURITIES EXCHANGE LIMITED  >  Benitec Biopharma Ltd    BLT   AU000000BLT8

BENITEC BIOPHARMA LTD

(BLT)
End-of-day quote. End-of-day quote AUSTRALIAN SECURITIES EXCHANGE LIMITED - 06/14
0.06 AUD   -6.25%
03/06BENITEC BIOPHARMA : Appendix 3B
PU
02/25BENITEC BIOPHARMA : Appendix 4D and Half Year Report
PU
2018BENITEC BIOPHARMA : Provides Update on BB-401 Cancer Treatment Program
PU
 SummaryQuotesChartsNewsCalendarCompanyFinancials 
Quotes 5-day view   End-of-day quote. End-of-day quote Australian Securities Exc…
06/07/2019 06/11/2019 06/12/2019 06/13/2019 06/14/2019 Date
0.073(c) 0.073(c) 0.07(c) 0.064(c) 0.06 Last
4 692 231 939 622 4 197 289 1 332 737 1 341 389 Volume
-39.17% 0.00% -4.11% -8.57% -6.25% Change
More quotes
Company
Benitec Biopharma Limited is a biotechnology company. The Company is engaged in progressing programs through the clinic; the commercialization of its Intellectual Property (IP); development of its therapeutic pipeline and pre-clinical programs, and funding, and protecting and building the IP estate. 
More about the company
Latest news on BENITEC BIOPHARMA LTD
03/06BENITEC BIOPHARMA : Appendix 3B
PU
02/25BENITEC BIOPHARMA : Appendix 4D and Half Year Report
PU
2018BENITEC BIOPHARMA : Provides Update on BB-401 Cancer Treatment Program
PU
2018BENITEC BIOPHARMA : Chairman's Presentation to Shareholders
PU
2018BENITEC BIOPHARMA : Appendix 4C - quarterly
PU
2018BENITEC BIOPHARMA : Appoints Senior Scientific Advisor
PU
2018BENITEC BIOPHARMA : Ceasing to be a substantial holder
PU
2018BENITEC BIOPHARMA : Axovant Announces Global Licensing Agreement for AXO-AAV-OPM..
AQ
2018BENITEC BIOPHARMA : Announces Global Licensing Agreement for BB-301 for Treatmen..
AQ
2018BENITEC BIOPHARMA : Axovant deepens gene therapy pipeline with Benitec deal
AQ
More news
Analyst Recommendations on BENITEC BIOPHARMA LTD
More recommendations
Sector news : Biotechnology & Medical Research - NEC
06/14REGENERON PHARMACEUTICALS : Says Early-Stage Results Positive for REGN1979 in Ly..
DJ
06/13GSK signs up gene-editing pioneers in drug discovery alliance
RE
06/11GENMAB : J&J's Janssen in Pact for HexaBody-CD38 License
DJ
05/21Global chemical firms urged to source responsibly after lethal China blast - ..
RE
05/15GILEAD SCIENCES : Novartis gets approval to sell Kymriah in Japan for $306,000
RE
More sector news : Biotechnology & Medical Research - NEC
Chart BENITEC BIOPHARMA LTD
Duration : Period :
Benitec Biopharma Ltd Technical Analysis Chart | MarketScreener
Full-screen chart
Income Statement Evolution
Managers
NameTitle
Jerel A. Banks Executive Chairman & Chief Executive Officer
Megan Boston Executive Director & Head-Operations Australia
Bryan Dulhunty Chief Financial Officer
Kerrie Boyd Director-Clinical Development
Peter Roelvink Senior Director-Research
Sector and Competitors
1st jan.Capitalization (M$)
BENITEC BIOPHARMA LTD-42.86%20
IQVIA HOLDINGS INC21.63%26 223
LONZA GROUP29.21%24 012
CELLTRION, INC.--.--%20 953
INCYTE CORPORATION22.20%17 061
EXACT SCIENCES CORPORATION73.98%13 037